Evidence map›Paper›PMID 37813909›Full record

ArticleScientific reports2023

Full publication of preprint articles in prevention research: an analysis of publication proportions and results consistency.

Isolde Sommer, Vincent Sunder-Plassmann, Piotr Ratajczak, Robert Emprechtinger, Andreea Dobrescu, Ursula Griebler, Gerald Gartlehner

Abstract read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Isolde SommerCochrane Austria, Department for Evidence-Based Medicine and Evaluation, Danube University Krems, Krems, Austria. isolde.sommer@donau-uni.ac.at.
Vincent Sunder-PlassmannCochrane Austria, Department for Evidence-Based Medicine and Evaluation, Danube University Krems, Krems, Austria.
Piotr RatajczakDepartment of Pharmacoeconomics and Social Pharmacy, Poznań University of Medical Sciences, Poznań, Poland.
Robert EmprechtingerFaculty of Health and Medicine, Danube University Krems, Krems, Austria.
Andreea DobrescuCochrane Austria, Department for Evidence-Based Medicine and Evaluation, Danube University Krems, Krems, Austria.
Ursula GrieblerCochrane Austria, Department for Evidence-Based Medicine and Evaluation, Danube University Krems, Krems, Austria.
Gerald GartlehnerCochrane Austria, Department for Evidence-Based Medicine and Evaluation, Danube University Krems, Krems, Austria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There is concern that preprint articles will lead to an increase in the amount of scientifically invalid work available. The objectives of this study were to determine the proportion of prevention preprints published within 12 months, the consistency of the effect estimates and conclusions between preprint and published articles, and the reasons for the nonpublication of preprints. Of the 329 prevention preprints that met our eligibility criteria, almost half (48.9%) were published in a peer-reviewed journal within 12 months of being posted. While 16.8% published preprints showed some change in the magnitude of the primary outcome effect estimate, 4.4% were classified as having a major change. The style or wording of the conclusion changed in 42.2%, the content in 3.1%. Preprints on chemoprevention, with a cross-sectional design, and with public and noncommercial funding had the highest probabilities of publication. The main reasons for the nonpublication of preprints were journal rejection or lack of time. The reliability of preprint articles for evidence-based decision-making is questionable. Less than half of the preprint articles on prevention research are published in a peer-reviewed journal within 12 months, and significant changes in effect sizes and/or conclusions are still possible during the peer-review process.

Indexed as

Health Services ResearchCross-Sectional StudiesReproducibility of Results

Identifiers

PMID37813909
PMCPMC10562443

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.